TOUJEO (Sanofi-Aventis Australia Pty Ltd)
Product name
TOUJEO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
170 working days (255)
Active ingredients
insulin glargine
Registration type
EOI
Indication
TOUJEO (solution for injection) is now also indicated for the treatment of diabetes mellitus in adolescents and children 6 years of age and older.